Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial. - Czepielewski MA; Garret Q; Vencio SAC; Rassi N; Faria MS; Senn CCP; Bronstein MD; Cerqueira MJAG; Neves ACL; Spinola-Castro AM; Cunha MPR; Leite NR; et al. (Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2021)